020 3389 7221 info@sarcoidosisuk.org
Select Page
The COVID-19 pandemic has forced many charities to re-think their current structures and processes in order to ensure they remain alive, and SarcoidosisUK is no exception to this. As a result, the charity will be looking to convert from its current structure as an Unincorporated Charity to a Limited Liability Charitable Incorporated Organisation (CIO).
Despite the past year and a half being particularly challenging for the charity sector, SarcoidosisUK saw significant growth over this period of time as patient demand for information and support reached an all time high. Whilst the charity’s growth is undoubtedly a great achievement, with it comes increased risk complexity for current members under the structure of an Unincorporated Charity. Under our current unincorporated structure, risks are not limited to SarcoidosisUK, but are borne by the members of the charity, whereas converting to a Limited Liability CIO limits the risk to the organisation.
The conversion to a Limited Liability CIO has only recently become an option for charities, yet will mitigate this risk to members and provide a much-needed step in the right direction to allow us to continue on a pathway of sustained growth.
SarcoidosisUK’s current Constitution & Articles no longer suit the position we are in today, furthering the need for the transition. The CIO structure will best suit the charity’s needs going forward, and SarcoidosisUK would request that members consider this when attending and voting during the next AGM (date to be announced in the coming weeks).
If you would like to find out more about the transition to a CIO, you can watch back a video with SarcoidosisUK Executive Chairperson Peter Tichbon where he explains the process in full here.
He will also be hosting a live Q&A session on Wednesday 1st December at 6pm over on our Facebook channel, so be sure to join in if you have specific questions you would like answered.
Our commitment remains to provide the highest level of support and information to the sarcoidosis community, whilst raising awareness on a national level and investing in world-leading research. Thank you for your continued support!

Share This